11 beta, 17 alpha, 21-Trihydroxy-1,4-pregnadien-3,20-dion 21-[(E,E)-3,7,11-trimethyl-2,6,10-dodecatriensäure ester]

11 beta ,17 alpha ,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-[(E,E)-3,7,11-trimethyl-2,6,10-dodecatrienoate] of the formula an antiinflammatory composition thereof and a method for the production thereof. 11 beta ,17 alpha ,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-[(E,E)-3,7,11-trimethyl-2,6,10...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: TERASAWA, MICHIO, NAKATSU-SHI OITA-KEN, JP, AJIOKA, HIROFUSA 86, AZA-NAGAEBOUJI, ITANO-GUN TOKUSHIMA-KEN, JP, ARIZONO, KENZO, NAKATSU-SHI OITA-KEN, JP, KANEHIRA, KOICHI, KURASHIKI-SHI OKAYAMA-KEN, JP, SHIONO, MANZO, OKAYAMA-SHI OKAYAMA-KEN, JP, MIZUSHIMA, YUTAKA, TOKYO-TO, JP, KOMURO, MASAHITO, TOKUSHIMA-SHI TOKUSHIMA-KEN, JP, NISHIDA, TAKASHI, KURASHIKI-SHI OKAYAMA-KEN, JP, IGARASHI, RIE, KAWASAKI-SHI KANAGAWA-KEN, JP, INOUE, MASAYUKI, KURASHIKI-SHI OKAYAMA-KEN, JP, HOSHI, KEIKO, YOKOHAMA-SHI KANAGAWA-KEN, JP, YAMAMOTO, NORIYUKI, TOKUSHIMA-SHI TOKUSHIMA-KEN, JP
Format: Patent
Sprache:ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator TERASAWA, MICHIO, NAKATSU-SHI OITA-KEN, JP
AJIOKA, HIROFUSA 86, AZA-NAGAEBOUJI, ITANO-GUN TOKUSHIMA-KEN, JP
ARIZONO, KENZO, NAKATSU-SHI OITA-KEN, JP
KANEHIRA, KOICHI, KURASHIKI-SHI OKAYAMA-KEN, JP
SHIONO, MANZO, OKAYAMA-SHI OKAYAMA-KEN, JP
MIZUSHIMA, YUTAKA, TOKYO-TO, JP
KOMURO, MASAHITO, TOKUSHIMA-SHI TOKUSHIMA-KEN, JP
NISHIDA, TAKASHI, KURASHIKI-SHI OKAYAMA-KEN, JP
IGARASHI, RIE, KAWASAKI-SHI KANAGAWA-KEN, JP
INOUE, MASAYUKI, KURASHIKI-SHI OKAYAMA-KEN, JP
HOSHI, KEIKO, YOKOHAMA-SHI KANAGAWA-KEN, JP
YAMAMOTO, NORIYUKI, TOKUSHIMA-SHI TOKUSHIMA-KEN, JP
description 11 beta ,17 alpha ,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-[(E,E)-3,7,11-trimethyl-2,6,10-dodecatrienoate] of the formula an antiinflammatory composition thereof and a method for the production thereof. 11 beta ,17 alpha ,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-[(E,E)-3,7,11-trimethyl-2,6,10-dodecatrienoate] of the present invention exhibits remarkably excellent antiinflammatory action and besides, displays reduced side effects and can be produced in high selectivity and good yield and conveniently.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DE68913778TT2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DE68913778TT2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DE68913778TT23</originalsourceid><addsrcrecordid>eNqNykEKAiEYhuHZtIjqDtKqQKHfiZlpXUYHcBcRNv41wqSiBs19ukkXy6ADtPo-Xp5xkQDIBZOiBGqiet_lx4HJYLpBB_ccGNA18wFvVmmDlpWUr5g2zn7ZcSGoWOZWUwCWgrlj6oaecVpRyMxpbFXOaOP79QhIMCYMp2kxuqo-4uy3k2K-F3J7YOjdGaNXLVpM552omg2Udd1Iycu_0AfzlD9d</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>11 beta, 17 alpha, 21-Trihydroxy-1,4-pregnadien-3,20-dion 21-[(E,E)-3,7,11-trimethyl-2,6,10-dodecatriensäure ester]</title><source>esp@cenet</source><creator>TERASAWA, MICHIO, NAKATSU-SHI OITA-KEN, JP ; AJIOKA, HIROFUSA 86, AZA-NAGAEBOUJI, ITANO-GUN TOKUSHIMA-KEN, JP ; ARIZONO, KENZO, NAKATSU-SHI OITA-KEN, JP ; KANEHIRA, KOICHI, KURASHIKI-SHI OKAYAMA-KEN, JP ; SHIONO, MANZO, OKAYAMA-SHI OKAYAMA-KEN, JP ; MIZUSHIMA, YUTAKA, TOKYO-TO, JP ; KOMURO, MASAHITO, TOKUSHIMA-SHI TOKUSHIMA-KEN, JP ; NISHIDA, TAKASHI, KURASHIKI-SHI OKAYAMA-KEN, JP ; IGARASHI, RIE, KAWASAKI-SHI KANAGAWA-KEN, JP ; INOUE, MASAYUKI, KURASHIKI-SHI OKAYAMA-KEN, JP ; HOSHI, KEIKO, YOKOHAMA-SHI KANAGAWA-KEN, JP ; YAMAMOTO, NORIYUKI, TOKUSHIMA-SHI TOKUSHIMA-KEN, JP</creator><creatorcontrib>TERASAWA, MICHIO, NAKATSU-SHI OITA-KEN, JP ; AJIOKA, HIROFUSA 86, AZA-NAGAEBOUJI, ITANO-GUN TOKUSHIMA-KEN, JP ; ARIZONO, KENZO, NAKATSU-SHI OITA-KEN, JP ; KANEHIRA, KOICHI, KURASHIKI-SHI OKAYAMA-KEN, JP ; SHIONO, MANZO, OKAYAMA-SHI OKAYAMA-KEN, JP ; MIZUSHIMA, YUTAKA, TOKYO-TO, JP ; KOMURO, MASAHITO, TOKUSHIMA-SHI TOKUSHIMA-KEN, JP ; NISHIDA, TAKASHI, KURASHIKI-SHI OKAYAMA-KEN, JP ; IGARASHI, RIE, KAWASAKI-SHI KANAGAWA-KEN, JP ; INOUE, MASAYUKI, KURASHIKI-SHI OKAYAMA-KEN, JP ; HOSHI, KEIKO, YOKOHAMA-SHI KANAGAWA-KEN, JP ; YAMAMOTO, NORIYUKI, TOKUSHIMA-SHI TOKUSHIMA-KEN, JP</creatorcontrib><description>11 beta ,17 alpha ,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-[(E,E)-3,7,11-trimethyl-2,6,10-dodecatrienoate] of the formula an antiinflammatory composition thereof and a method for the production thereof. 11 beta ,17 alpha ,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-[(E,E)-3,7,11-trimethyl-2,6,10-dodecatrienoate] of the present invention exhibits remarkably excellent antiinflammatory action and besides, displays reduced side effects and can be produced in high selectivity and good yield and conveniently.</description><edition>5</edition><language>ger</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; STEROIDS</subject><creationdate>1994</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19940728&amp;DB=EPODOC&amp;CC=DE&amp;NR=68913778T2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19940728&amp;DB=EPODOC&amp;CC=DE&amp;NR=68913778T2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TERASAWA, MICHIO, NAKATSU-SHI OITA-KEN, JP</creatorcontrib><creatorcontrib>AJIOKA, HIROFUSA 86, AZA-NAGAEBOUJI, ITANO-GUN TOKUSHIMA-KEN, JP</creatorcontrib><creatorcontrib>ARIZONO, KENZO, NAKATSU-SHI OITA-KEN, JP</creatorcontrib><creatorcontrib>KANEHIRA, KOICHI, KURASHIKI-SHI OKAYAMA-KEN, JP</creatorcontrib><creatorcontrib>SHIONO, MANZO, OKAYAMA-SHI OKAYAMA-KEN, JP</creatorcontrib><creatorcontrib>MIZUSHIMA, YUTAKA, TOKYO-TO, JP</creatorcontrib><creatorcontrib>KOMURO, MASAHITO, TOKUSHIMA-SHI TOKUSHIMA-KEN, JP</creatorcontrib><creatorcontrib>NISHIDA, TAKASHI, KURASHIKI-SHI OKAYAMA-KEN, JP</creatorcontrib><creatorcontrib>IGARASHI, RIE, KAWASAKI-SHI KANAGAWA-KEN, JP</creatorcontrib><creatorcontrib>INOUE, MASAYUKI, KURASHIKI-SHI OKAYAMA-KEN, JP</creatorcontrib><creatorcontrib>HOSHI, KEIKO, YOKOHAMA-SHI KANAGAWA-KEN, JP</creatorcontrib><creatorcontrib>YAMAMOTO, NORIYUKI, TOKUSHIMA-SHI TOKUSHIMA-KEN, JP</creatorcontrib><title>11 beta, 17 alpha, 21-Trihydroxy-1,4-pregnadien-3,20-dion 21-[(E,E)-3,7,11-trimethyl-2,6,10-dodecatriensäure ester]</title><description>11 beta ,17 alpha ,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-[(E,E)-3,7,11-trimethyl-2,6,10-dodecatrienoate] of the formula an antiinflammatory composition thereof and a method for the production thereof. 11 beta ,17 alpha ,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-[(E,E)-3,7,11-trimethyl-2,6,10-dodecatrienoate] of the present invention exhibits remarkably excellent antiinflammatory action and besides, displays reduced side effects and can be produced in high selectivity and good yield and conveniently.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>STEROIDS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1994</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNykEKAiEYhuHZtIjqDtKqQKHfiZlpXUYHcBcRNv41wqSiBs19ukkXy6ADtPo-Xp5xkQDIBZOiBGqiet_lx4HJYLpBB_ccGNA18wFvVmmDlpWUr5g2zn7ZcSGoWOZWUwCWgrlj6oaecVpRyMxpbFXOaOP79QhIMCYMp2kxuqo-4uy3k2K-F3J7YOjdGaNXLVpM552omg2Udd1Iycu_0AfzlD9d</recordid><startdate>19940728</startdate><enddate>19940728</enddate><creator>TERASAWA, MICHIO, NAKATSU-SHI OITA-KEN, JP</creator><creator>AJIOKA, HIROFUSA 86, AZA-NAGAEBOUJI, ITANO-GUN TOKUSHIMA-KEN, JP</creator><creator>ARIZONO, KENZO, NAKATSU-SHI OITA-KEN, JP</creator><creator>KANEHIRA, KOICHI, KURASHIKI-SHI OKAYAMA-KEN, JP</creator><creator>SHIONO, MANZO, OKAYAMA-SHI OKAYAMA-KEN, JP</creator><creator>MIZUSHIMA, YUTAKA, TOKYO-TO, JP</creator><creator>KOMURO, MASAHITO, TOKUSHIMA-SHI TOKUSHIMA-KEN, JP</creator><creator>NISHIDA, TAKASHI, KURASHIKI-SHI OKAYAMA-KEN, JP</creator><creator>IGARASHI, RIE, KAWASAKI-SHI KANAGAWA-KEN, JP</creator><creator>INOUE, MASAYUKI, KURASHIKI-SHI OKAYAMA-KEN, JP</creator><creator>HOSHI, KEIKO, YOKOHAMA-SHI KANAGAWA-KEN, JP</creator><creator>YAMAMOTO, NORIYUKI, TOKUSHIMA-SHI TOKUSHIMA-KEN, JP</creator><scope>EVB</scope></search><sort><creationdate>19940728</creationdate><title>11 beta, 17 alpha, 21-Trihydroxy-1,4-pregnadien-3,20-dion 21-[(E,E)-3,7,11-trimethyl-2,6,10-dodecatriensäure ester]</title><author>TERASAWA, MICHIO, NAKATSU-SHI OITA-KEN, JP ; AJIOKA, HIROFUSA 86, AZA-NAGAEBOUJI, ITANO-GUN TOKUSHIMA-KEN, JP ; ARIZONO, KENZO, NAKATSU-SHI OITA-KEN, JP ; KANEHIRA, KOICHI, KURASHIKI-SHI OKAYAMA-KEN, JP ; SHIONO, MANZO, OKAYAMA-SHI OKAYAMA-KEN, JP ; MIZUSHIMA, YUTAKA, TOKYO-TO, JP ; KOMURO, MASAHITO, TOKUSHIMA-SHI TOKUSHIMA-KEN, JP ; NISHIDA, TAKASHI, KURASHIKI-SHI OKAYAMA-KEN, JP ; IGARASHI, RIE, KAWASAKI-SHI KANAGAWA-KEN, JP ; INOUE, MASAYUKI, KURASHIKI-SHI OKAYAMA-KEN, JP ; HOSHI, KEIKO, YOKOHAMA-SHI KANAGAWA-KEN, JP ; YAMAMOTO, NORIYUKI, TOKUSHIMA-SHI TOKUSHIMA-KEN, JP</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DE68913778TT23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ger</language><creationdate>1994</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>STEROIDS</topic><toplevel>online_resources</toplevel><creatorcontrib>TERASAWA, MICHIO, NAKATSU-SHI OITA-KEN, JP</creatorcontrib><creatorcontrib>AJIOKA, HIROFUSA 86, AZA-NAGAEBOUJI, ITANO-GUN TOKUSHIMA-KEN, JP</creatorcontrib><creatorcontrib>ARIZONO, KENZO, NAKATSU-SHI OITA-KEN, JP</creatorcontrib><creatorcontrib>KANEHIRA, KOICHI, KURASHIKI-SHI OKAYAMA-KEN, JP</creatorcontrib><creatorcontrib>SHIONO, MANZO, OKAYAMA-SHI OKAYAMA-KEN, JP</creatorcontrib><creatorcontrib>MIZUSHIMA, YUTAKA, TOKYO-TO, JP</creatorcontrib><creatorcontrib>KOMURO, MASAHITO, TOKUSHIMA-SHI TOKUSHIMA-KEN, JP</creatorcontrib><creatorcontrib>NISHIDA, TAKASHI, KURASHIKI-SHI OKAYAMA-KEN, JP</creatorcontrib><creatorcontrib>IGARASHI, RIE, KAWASAKI-SHI KANAGAWA-KEN, JP</creatorcontrib><creatorcontrib>INOUE, MASAYUKI, KURASHIKI-SHI OKAYAMA-KEN, JP</creatorcontrib><creatorcontrib>HOSHI, KEIKO, YOKOHAMA-SHI KANAGAWA-KEN, JP</creatorcontrib><creatorcontrib>YAMAMOTO, NORIYUKI, TOKUSHIMA-SHI TOKUSHIMA-KEN, JP</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TERASAWA, MICHIO, NAKATSU-SHI OITA-KEN, JP</au><au>AJIOKA, HIROFUSA 86, AZA-NAGAEBOUJI, ITANO-GUN TOKUSHIMA-KEN, JP</au><au>ARIZONO, KENZO, NAKATSU-SHI OITA-KEN, JP</au><au>KANEHIRA, KOICHI, KURASHIKI-SHI OKAYAMA-KEN, JP</au><au>SHIONO, MANZO, OKAYAMA-SHI OKAYAMA-KEN, JP</au><au>MIZUSHIMA, YUTAKA, TOKYO-TO, JP</au><au>KOMURO, MASAHITO, TOKUSHIMA-SHI TOKUSHIMA-KEN, JP</au><au>NISHIDA, TAKASHI, KURASHIKI-SHI OKAYAMA-KEN, JP</au><au>IGARASHI, RIE, KAWASAKI-SHI KANAGAWA-KEN, JP</au><au>INOUE, MASAYUKI, KURASHIKI-SHI OKAYAMA-KEN, JP</au><au>HOSHI, KEIKO, YOKOHAMA-SHI KANAGAWA-KEN, JP</au><au>YAMAMOTO, NORIYUKI, TOKUSHIMA-SHI TOKUSHIMA-KEN, JP</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>11 beta, 17 alpha, 21-Trihydroxy-1,4-pregnadien-3,20-dion 21-[(E,E)-3,7,11-trimethyl-2,6,10-dodecatriensäure ester]</title><date>1994-07-28</date><risdate>1994</risdate><abstract>11 beta ,17 alpha ,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-[(E,E)-3,7,11-trimethyl-2,6,10-dodecatrienoate] of the formula an antiinflammatory composition thereof and a method for the production thereof. 11 beta ,17 alpha ,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-[(E,E)-3,7,11-trimethyl-2,6,10-dodecatrienoate] of the present invention exhibits remarkably excellent antiinflammatory action and besides, displays reduced side effects and can be produced in high selectivity and good yield and conveniently.</abstract><edition>5</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language ger
recordid cdi_epo_espacenet_DE68913778TT2
source esp@cenet
subjects CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
STEROIDS
title 11 beta, 17 alpha, 21-Trihydroxy-1,4-pregnadien-3,20-dion 21-[(E,E)-3,7,11-trimethyl-2,6,10-dodecatriensäure ester]
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T06%3A32%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TERASAWA,%20MICHIO,%20NAKATSU-SHI%20OITA-KEN,%20JP&rft.date=1994-07-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDE68913778TT2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true